Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.
OBJECTIVE
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention interventions could offer a powerful strategy when combined. In anticipation of combination HIV prevention programs and research studies we estimated the population-level impact of combining effective scalable interventions at high population coverage, determined the factors that influence this impact, and estimated the synergy between the components.


METHODS
We used a mathematical model to investigate the effect on HIV incidence of a combination HIV prevention intervention comprised of high coverage of HIV testing and counselling, risk reduction following HIV diagnosis, male circumcision for HIV-uninfected men, and antiretroviral therapy (ART) for HIV-infected persons. The model was calibrated to data for KwaZulu-Natal, South Africa, where adult HIV prevalence is approximately 23%.


RESULTS
Compared to current levels of HIV testing, circumcision, and ART, the combined intervention with ART initiation according to current guidelines could reduce HIV incidence by 47%, from 2.3 new infections per 100 person-years (pyar) to 1.2 per 100 pyar within 4 years and by almost 60%, to 1 per 100 pyar, after 25 years. Short-term impact is driven primarily by uptake of testing and reductions in risk behaviour following testing while long-term effects are driven by periodic HIV testing and retention in ART programs. If the combination prevention program incorporated HIV treatment upon diagnosis, incidence could be reduced by 63% after 4 years and by 76% (to about 0.5 per 100 pyar) after 15 years. The full impact of the combination interventions accrues over 10-15 years. Synergy is demonstrated between the intervention components.


CONCLUSIONS
High coverage combination of evidence-based strategies could generate substantial reductions in population HIV incidence in an African generalized HIV epidemic setting. The full impact could be underestimated by the short assessment duration of typical evaluations.
Global Health, University of Washington, Seattle, Washington, United States of America. ramzi.alsallaq@gmail.com
Ramzi A
RA
Alsallaq
Jared M
JM
Baeten
Connie L
CL
Celum
James P
JP
Hughes
Laith J
LJ
Abu-Raddad
Ruanne V
RV
Barnabas
Timothy B
TB
Hallett
D000293:Adolescent; D000328:Adult; D044966:Anti-Retroviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002944:Circumcision, Male / Q000706:statistics & numerical data; D003376:Counseling / Q000706:statistics & numerical data; D019353:Endemic Diseases; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D015995:Prevalence; D011322:Primary Prevention / Q000379:methods* / Q000706:statistics & numerical data; D012309:Risk-Taking; D013019:South Africa / Q000453:epidemiology
D044966:Anti-Retroviral Agents